Biotech startups in Changping, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Huixin Medical Valley | Changping | Series A | $14.3M | 2026-01-07 |
| Shenji Changhua | Changping | Seed | $13.8M | 2024-08-01 |
| Wisbiom | Changping | Seed | $1.4M | 2023-12-18 |
3 rows of the CSV in 5 of its 18 columns.
- The 26 biotech startups in Changping, China have raised $607.3M in total.
- 7 of them closed their most recent round in the last 12 months, $86.1M combined.
- The largest of those rounds is Gene+'s $42.4M Series D, dated December 2025.
- The most recent is Huaxia Yingtai's $29.4M Series C on 6 July 2026.
- Health care is the most common other sector, with 25 companies (96%).
- 42% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (40% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 26| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Huixin Medical Valley | Huixin Medical Valley develops cell therapies for neurological illnesses as a biopharmaceutical company. | Biotech | Series A | $14.3M | 2026-01-07 | $14.3M | Green Pine Capital Partners, Jiuzhi Ziben, Beijing Venture Capital | 51 to 100 | 2021 |
| Shenji Changhua | Shenji Changhua is a biotechnology company focused on neurological diseases such as ALS. | Biotech | Seed | $13.8M | 2024-08-01 | $16.5M | Tsinghua Capital, MSA Capital, Zhongbo Juli | 11 to 50 | 2021 |
| Wisbiom | Wisbiom develops microecological preparations and microbiome-related products. | Biotech | Seed | $1.4M | 2023-12-18 | $1.4M | Hengxu Capital, ELIM Capital | 2017 |
Table 1. Biotech startups in Changping, China: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 26.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Huixin Medical Valley | Huixin Medical Valley develops cell therapies for neurological illnesses as a biopharmaceutical company. | Biotech | Series A | $14.3M | 2026-01-07 | $14.3M | Green Pine Capital Partners, Jiuzhi Ziben, Beijing Venture Capital | 51 to 100 | 2021 |
Table 2. Biotech startups in Changping, China: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Jiuzhi Ziben | Venture capital firm | 1 | 4% | 1 | Huixin Medical Valley | |
| 2 | Beijing Venture Capital | Venture capital firm | Beijing, China | 1 | 4% | 1 | Huixin Medical Valley |
| 3 | Green Pine Capital Partners | Venture capital firm | Shenzhen, China | 1 | 4% | 1 | Huixin Medical Valley |
| 4 | MSA Capital | Private equity firm | Beijing, China | 1 | 4% | ||
| 5 | Zhongbo Juli | Private equity firm | Chaoyang, China | 1 | 4% | ||
| 6 | Tsinghua Capital | Venture capital firm | Haidian, China | 1 | 4% | ||
| 7 | Chengwei Capital | Venture capital firm | Shanghai, China | 1 | 4% | ||
| 8 | Zhongsu Capital | Private equity firm | Shanghai, China | 1 | 4% | ||
| 9 | Wuxi Capital | Angel group | Wuxi Shi, China | 1 | 4% | ||
| 10 | 3E Bioventures | Venture capital firm | Beijing, China | 1 | 4% | ||
| 11 | Empower Investment | Venture capital firm | Shanghai, China | 1 | 4% | ||
| 12 | Hengxu Capital | Private equity firm | Jiading, China | 1 | 4% | ||
| 13 | ELIM Capital | Venture capital firm | Ningbo, China | 1 | 4% | ||
| 14 | Zhuhai High Tech Investment | Venture capital firm | Zhuhai, China | 1 | 4% | ||
| 15 | Guangda Huitong | Private equity firm | Chaoyang, China | 1 | 4% |
Table 3. Biotech startups in Changping, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 25 | 96% | $607.3M |
| Software | 1 | 4% | $2.0M |
Table 4. Biotech startups in Changping, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 6 | 23% | $10.0M |
| Series A | 8 | 31% | $14.3M |
| Series B | 8 | 31% | $15.0M |
| Series C | 3 | 12% | $29.4M |
| Series D+ | 1 | 4% | $42.4M |
Table 5. Biotech startups in Changping, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| July 2026 | 2 | 29% | $29.4M |
| May 2026 | 2 | 29% | |
| January 2026 | 2 | 29% | $14.3M |
| December 2025 | 1 | 14% | $42.4M |
Table 6. Biotech startups in Changping, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 6 | 23% | $43.7M |
| 2025 | 3 | 12% | $56.5M |
| 2024 | 6 | 23% | $26.5M |
| 2023 | 1 | 4% | $1.4M |
| 2022 | 3 | 12% | $52.0M |
| 2021 | 3 | 12% | $77.2M |
Table 7. Biotech startups in Changping, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 8% |
| 2020 to 2022 | 9 | 35% |
| 2015 to 2019 | 10 | 38% |
| 2010 to 2014 | 4 | 15% |
| Before 2010 | 1 | 4% |
Table 8. Biotech startups in Changping, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 11 to 50 | 8 | 40% |
| 51 to 100 | 5 | 25% |
| 101 to 250 | 6 | 30% |
| 501 to 1,000 | 1 | 5% |
Table 9. Biotech startups in Changping, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Changping, China. On 16 November 2026 that is 26 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 26 rows: 10 have no round amount, 0 no city and 5 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Changping, China are on the list?
- 26, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 26 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.